0001193125-26-208922
SEC filingQ3 revenue declined 25% to $43.7M due to MindBody GLP-1 System weakness and inventory obsolescence, pressuring profitability despite gross margins holding at 79.0% and lower commissions as a percentage of revenue from optimized promotions.
Operating income declined 58.6% to $1.7 million (3.8% operating margin), as selling, general, and administrative expenses rose as a percentage of the lower revenue base. This leverage challenge stems directly from the sales downturn, offsetting efficiencies elsewhere. Notably, commissions and incentives expenses decreased as a percentage of revenue compared to the prior year, attributable to the timing and magnitude of promotional programs plus changes in the mix of customers and independent consultants within Active Accounts. Net income followed suit, falling 60.7% to $1.4 million, with diluted EPS at $0.11 versus $0.26.
Cash generation remained disciplined, with net cash from operating activities at $5.5 million—down from $10.8 million but sufficient to produce $2.9 million in free cash flow after capital expenditures doubled to $2.5 million. The company has historically relied on operational cash flows to fund activities, occasionally supplementing with debt for repurchases or strategic moves like the LoveBiome acquisition. Elevated capex likely reflects integration needs post-acquisition, preserving liquidity for such opportunities.